Conférences - Pharmacologie et développement des médicaments

SMi Group

Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services and will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Discussing the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability.

Tél.: [+44 (0) 20 7827 6088];     Email.: hsidhu@smi-online.co.uk

pharmaceutical, Prefilled Syringes

This conference focuses on the design, synthesis and clinical validation of new drug delivery vehicles. This conference is designed to bridge the gap between basic science and unmet clinical needs.

Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com

Therapeutic gene editing, Extrahepatic delivery of nucleic acids, Characterization of therapeutic nanoparticles and control strategies for manufacturing, New linkers for triggered or controlled release, New long acting technologies, Tumor targeting with nanoparticles, recent progress and challenges

Pharmacogénétique, Médecine personnalisée,    Législation en médecine et pharmacologie

Biophysical Society (BPS)

Antibiotic resistance is a pressing global challenge to human health, and biophysics and bioengineering have much to offer to the global response to this challenge. This meeting will help bring together scientists working to diagnose, understand, and overcome antibiotic resistance. Engineering approaches and the biophysical methodologies of spectroscopy, single-molecule and single-cell microscopy, computational modeling, and development of functional assays are uniquely suited to help answer these questions. This meeting seeks to explore the interface between biophysical research and the microbiology of drug resistance, highlighting the breadth of work that spans these two fields and encouraging new synergies to tackle this global health problem.

Biophysique,    Biologie moléculaire

Zhenwei Exhibitions

Guangzhou International Biotechnology Conference&Expo will be held in September 2020. This event is jointly hosted by industry associations and Zhenwei Exhibition Group. The convention consists of six major sessions. More than a dozen of domestic and foreign business, academic, and political leaders will be invited to attend and discuss the hot topics and trends in the bio-industry chain, integrating policy orientation, market investment, technology research and development, and clinical applications.

Tél.: [+86 20 8395 3212];     Email.: yona_zhenweiexpo@126.com

Lab tech&Equipment Medical Lab&IVD Biopharma Ingredients Biotech Services Engineering Quality Management&Safety

Génie biomédical,    Cellules souches

Tél.: [+31887569555];     Email.: congress2020@ecnp.eu

brain disorder, health, neurology, pharma, mental disorder

Neurologie,    Psychiatrie

FISV is a non-profit organization whose aim is to coodinate the activities of scientific societies at national and international levels to promote the development of scientific research in Life Sciences. This year the congress edition has a drafted program aiming at fostering interdisciplinary exchange at the forefront of the life sciences spanning from the new genomic editing technology and precision medicine to sustainable agricultural approaches. Internationally renowned scientists from Italy and abroad will present their most recent data; in addition, the meeting will also allow several early career Italian and foreign scientists to present their research in a highly stimulating scientific environment. We will also have round tables on selected current topics as well as talks dedicated to a broader audience to enhance the interaction between scientists and non scientists. The FISV Congress will bring together scientists from across the world and will offer an invaluable opportunity to discuss scientific issues in the fields of Life Sciences. The congress will be opened to all researchers from Italy and abroad and will include a full range of academic sessions, plenary lectures, and social/cultural events. We plan to have talks by more than 30 invited speakers . Other researchers, mainly young researcher, will get an opportunity to showcase their work through the mini symposium sessions and during oral flash poster presentations.

Tél.: [00393392684792];     Email.: giulia.piaggio@ifo.gov.it

New technologies of genetic modification and biodiversity • Challenging Homo sapiens biounicity • New genomic technologies and biodiversity • The fall of human races, the many human species and their relationships • Diversity and evolution of genomes • From the plastics revolution to the bioplastics evolution • Insights into insect biology to control pathogen vectors and agricultural pests • Present and future of single cell studies • Microbiome modulation for improving human and plant health • Novel therapeutic targets for precision medicine

Biologie,    Biotechnologie

Complianceonline

This course is designed to cater for employees of pharmaceutical companies who would like an understanding of the drug development and regulatory approval process. The course starts by considering the global pharmaceutical market, important therapeutic areas and the roles of different pharmaceutical professionals in the development process, as well as a definition of drugs and medical devices. The drug development process, from discovery to post-marketing surveillance, is then explained. Topics include the identification of drug targets, synthesis of chemical drugs and the development of biologics, pharmacokinetics and toxicity screening, pre-clinical development, clinical studies, regulatory submissions, managing post-approval change, pharmacovigilance and an overview of regulations governing drug manufacture and distribution.

Tél.: [18887172436];     Email.: referral@complianceonline.com

Drug development process, identification of drug targets, synthesis of chemical drugs, the development of biologics, pharmacokinetics, toxicity screening, pre-clinical development, clinical studies, regulatory submissions, managing post-approval change, pharmacovigilance, governing drug manufacture and distribution fda regulations, global pharmaceutical market size

EBD Group

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. For this year’s digital event, BioPharm America will focus on Innovation and Investing, with the added collaboration of a number of diverse partners, whose unique offerings include live and recorded panel discussions, fireside chats, and company presentations from AI Applications for Drug Delivery and Development, LeadingBiotech Boston CEO & BD, Drug Delivery Partnerships, as well as the Xcelerate Startup Pitch Competition. The Collaboration Close-up forum will feature moderated discussion examining a specific collaboration, partnership or deal, with representatives from the two parties. Featured program elements will be available on demand, either live with Q&A (and also recorded) or prerecorded. Startup companies, established biotech and entrepreneurs attend in search of finance, pharma and development partners from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.

Registration;     Tél.: [7609300500];     Email.: conferences@ebdgroup.com

partnering, early stage, investing, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Front Line Genomics

Real data. Real case studies. Real evidence. Real connections. D4 Europe is about finding the golden nuggets. Uncovering the truth. Benchmarking against other pharma. Learning from successes and failures. Understanding the context behind the results. Seeing the evidence – the actual data generated in projects. Getting past the headlines, into the substance. And importantly, understanding where you will see real, near term results in your pharma R&D. To achieve those things requires a more intimate meeting. One where you can meet and spend time with other attendees, as well as learn from the talks and discussions on the agenda. D4 Europe was designed by pharma, for pharma – a friendly gathering of around 120 people. It’s about bringing back tools, tactics and ideas that will make a difference to your drug discovery and development programs now. Not in 10 years’ time. Patients are waiting.

Events Team;     Tél.: [02081918810];     Email.: contact@frontlinegenomics.com

data, drug development, research, drug discovery, data science, drug design, fair data, pharma, ai, machine learning, data driven research

SMi Group

The aseptic processing industry has seen many changes during its progression towards the 21st century. With advances in innovative therapeutic manufacturing such as ATMPs, pragmatic barrier system applications, adaptability and modularity in fill finish, robotics and automation, small and agile product manufacturing, just to name a few. In 2018, the global aseptic processing market was valued over $56 trillion and is estimated to increase in net revenue upwards $124 trillion by 2027, with a CAGR growth of 9.18%.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Aseptic Processing, Pharmaceutical Aseptic Processing, Environmental Monitoring, EM, ATMP, Advanced Therapy Media Fill, GMP, Contaminant Particles, Medicinal Product, Pharmaceutical Microbiology, Fill Finish, Media Fill, Isolators, Microbiology, Aseptic Technique, Sterility, Bioburden, Mycoplasma, Quality Control, Rapid Microbial Methods, Data Integrity, Risk Assessments, Endotoxins, Microbiome

Législation en médecine et pharmacologie,    Formation continue (en general)

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Biogate Scientific Center welcomes Vaccines Summit Ohio (VSOhio20) in Columbus, OH from October 05-07, 2020. VSOhio20 will cover a broad range of topics like animal models, clinical trials, big data, and analytics. The summit will bring together participants from around the globe, including high-level political decision-makers, health ministers, UN organizations, NGOs, academia representatives, renowned researchers and healthcare professionals, vaccine industry CEOs, celebrities and social media influencers who actively support vaccination.

Tél.: [+1 410 246 4289];     Email.: sachin@bsc.events

Vaccine Technology, Animal Models, Influenza Vaccines, Vaccine Safety Science, Regulatory Science, Clinical Evaluation, Nonclinical Development, Vaccine Hesitancy, Big data and Analytics

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

CELforPharma

1 day training course delivered by Dr. Paul Craddy & Dr. Graham Foxon. Grasp the meaning, concepts, terminology, methodologies and research techniques of Real World Evidence (RWE) in the context of optimising Market Access - Know what each stakeholder type expects from RWE, which key data to use and how to develop a successful RWE study – Learn how to incorporate RWE into the product pre-launch process.

Director Commercial Communications;     Tél.: [+32 2 709 01 43];     Email.: inge.cornelis@celforpharma.com

The fundamental concepts and principles for utilising Real World Evidence (RWE) towards optimising Market Access. The value RWE adds over RCTs over a product’s entire lifecycle. The terminology used within the world of RWE, such as the exact difference between Real World Evidence and Real World Data (RWD). Why RWE is important to regulators, payers, physicians and pharma and how to tailor the evidence to their specific needs. The common sources of data available for RWE and how to assess the robustness of the data. The critical success factors when developing a RWE study. How to effectively incorporate RWE into product launch decisions.

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

EBD Group GmbH

For more than 25 years BIO-Europe has played an instrumental role in bringing biopharma and investment leaders together, to facilitate innovation and medical breakthroughs. Last year more than 26,000 one-to-one meetings were facilitated using our proprietary platform, partneringONE®. Additionally, the event features pitches from biotech companies and academic innovators as well as insights from industry leaders in sessions and fireside chats. The 26th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe, though in 2020 by necessity we have gone fully digital and expanded the format to four 24-hour days to accommodate partnering meetings all over the world. Over 4,400 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and company presentations, and showcasing companies and sponsors (all of which will be pre-recorded and available to view throughout the event) along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to do business.

Registration;     Tél.: [T: +49 89 2388 756-43];     Email.: conferences@ebdgroup.com

partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, life science

SMi Group

SMi Group are pleased to announce the 2nd Annual Next Generation Pharmaceutical Cleanroom Europe Conference. An event that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Annex 1, ISO 14644, GMP, RMM, Rapid Micro Methods, Contamination recovery rates, Cleanroom, Mycoplasma, Data Integrity, Environmental monitoring, HVAC system, Contamination Control, RABS, restricted-access barrier system

Gestion des données cliniques, télésanté,    Médecine translationnelle, essais cliniques

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

CELforPharma

2 day training course delivered by David Wright & Pijush Bose. Learn how to uncover the unmet needs of strategic accounts and to develop patient-centric strategies that drive value for both your company, your account and patients – Know how to design and organise well-coordinated multi-functional account teams that result in much more effective KAM – Learn how to set up a KAM plan and to measure KAM success.

Director Commercial Communications;     Tél.: [+32 2 709 01 43];     Email.: inge.cornelis@celforpharma.com

How to develop patient-centric strategies that drive value for both your company, your account and patients. Approaches to uncover the unmet needs of Key Accounts. Analytical tools for discovering new growth opportunities within Key Accounts. How to prioritise triple-win opportunities for optimal value creation. What well-coordinated multi-functional account teams look like, and how such teams result in much more effective KAM. Best practices for setting Account Plan KPIs and for measuring Key Account success organisationally.

Understand the marketing principles that determine a pharmaceutical’s commercial success - Learn how your function can contribute to a pharma brand’s success in the new environment - Know how pharma marketers take strategic and tactical decisions - Gain ideas for cross-functional synergies that benefit a brand’s success.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

ICON CONFERENCES LLC

ICON Team welcomes you to attend “International Forum on Pharmacology & Nanotechnology” which is going to be held in Singapore. IFPN 2021 hosted by the Global Experts of ICON Events. This IFPN 2021 brings a perfect networking platform for experts to share their latest research and advancements in Pharmacology and associated fields. IFPN 2021 establishes a strong and immortal network between Peers, Scientific experts, and budding researchers in related fields across the globe. This will cover important, burning, and cutting-edge topics in Pharmacology and associated fields. We are anticipating more than 100 participants including Speakers, Students, and Delegates from all over the world to attend the conference.

Tél.: [9493742114];     Email.: customerservice@iconconferences.org

Pharmacology 2021, Nanotechnology 2021, Top International Conference on Pharmacology 2021, Upcoming Event on Pharma, Workshop, Symposium

ICPPN Germany 2021

ICPPN Germany 2021 welcomes all participants throughout the world to attend the International Conference on Pharmacy and Pharma Network held on June 28-30, 2021 in Germany. The Conference deals with the theme on "Recent Innovations and Advances in Pharmacy and Pharma Networks" and it has a branch of Scientific Sessions concerned with the departments of Pharmacology, Pharmacognosy, Toxicology, Pharmaceutical Sciences, Clinical Pharmacy, Biopharmaceutics and which included with subdivisions they are Hospital Pharmacy, Industrial Pharmacy, Pharmaceutical Biotechnology, Medicinal Chemistry, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology. Pharma Germany 2021 is a chance to extend and exhibit your ideas and explore the new innovations with experts from everywhere throughout the globe. The Conference serves researchers from academia and industry and intended to be of interest to a broad audience of Pharmaceutical, Medical and Health professionals, Worldwide pharmacists, Professors, researchers, they will present their novel research and provide an insight to the current research and future expansions in pharmacy and pharma network.

International Conference on Pharmacy and Pharma Network;     Tél.: [+601650835772];     Email.: sandrauman28@gmail.com

Pharmacognosy, Pharmaceutical Nanotechnology and Nanomedicine, Pharmaceutical Jurisprudence, Medicinal Chemistry, Industrial & Pharmacy Practice, Pharmacogenetics and Genomics, Bio-Pharmaceutics, Pharmacology, Community Pharmacy, Clinical Pharmacy, Pharmacovigilance, Pharmaceutical Manufacturers Global cGMP Compliance, Pharmaceutical Biotechnology Pharmaceutical Microbiology, Pharmacy and Pharmaceutical Sciences, Immunotherapy and Vaccines in Drug delivery, Pharmacotherapeutics, Molecular drug targets and delivery, Pharmaceutical Development, Toxicology, Hospital Pharmacy, Organic and Inorganic Chemistry, Veterinary Pharmacy

Législation en médecine et pharmacologie,    Pharmacogénétique, Médecine personnalisée